HB 681: Update Opioid Abatement Treatment Program Rules. - North Carolina

A1: ATQ-29-V-2 → Edition 1 · 8 edits

MODERATE

This bill updates North Carolina's opioid treatment program rules to better align with federal regulations, removing barriers that previously limited patient access to care. The changes eliminate outdated requirements like home stability checks and structured counseling schedules, while prohibiting administrative discharges for missed doses or counseling nonparticipation.

Scope change

The bill applies to outpatient opioid treatment programs regulated by the Commission for Mental Health, Developmental Disabilities, and Substance Use Services, specifically amending rules in 10A NCAC 27G .3600 through 10A NCAC 27G .3605.

ELIGIBILITY

Eliminated home environment stability and social relationships as eligibility criteria for take-home medication

REQUIREMENT

Removed structured counseling schedules to allow more flexible, patient-centered care

Eliminated the requirement for observed urine drug testing

Explicitly prohibited administrative discharge for continued substance use, missed doses, and nonparticipation in ancillary services

Explicitly permitted OTPs to administer methadone to patients not enrolled with the OTP

Reduced required drug testing frequency to match federal regulations

Mandated engagement with current and former OTP clients and providers for input on additional rule changes

TIMELINE

Required publication of proposed rule amendments by July 1, 2025

Filed → A1: ATQ-29-V-2 · 1 edit

MINOR

This amendment modifies House Bill 681 to require the State Opioid Treatment Authority to review patient discharge policies related to substance use, missed doses, and nonparticipation in counseling. The change shifts focus from explicitly prohibiting administrative discharge for these reasons to requiring a policy review process, while maintaining the bill's overall goal of aligning state opioid treatment rules with federal regulations.

REQUIREMENT

Changed requirement from explicitly prohibiting administrative discharge for substance use, missed doses, and counseling nonparticipation to requiring the State Opioid Treatment Authority to review discharge policies related to these issues.

Edition 2 → Edition 3 · 2 edits

MINOR

This bill revision updates the rules for North Carolina's opioid abatement treatment program by removing a patient's home stability as a requirement for take-home medication and shifting the policy on discharge from a prohibition to a review requirement. These changes aim to align state regulations with federal standards that prioritize patient-centered, individualized care while reducing barriers to accessing treatment.

ELIGIBILITY

Eliminated the requirement that a patient's home environment and social relationships must be stable to qualify for take-home medication.

REQUIREMENT

Changed the rule regarding patient discharge from a strict prohibition on administrative discharge for substance use, missed doses, or nonparticipation in counseling to a requirement that the State Opioid Treatment Authority review these discharge policies.

Edition 1 → Edition 2 · 4 edits

MODERATE

This bill update modifies rules for Opioid Treatment Programs (OTPs) in North Carolina to better align with federal regulations and improve patient access to care. Key changes include allowing OTPs to administer methadone to patients not enrolled at their facility, adjusting drug testing frequency requirements, and extending the deadline for publishing proposed rule amendments from July 2025 to January 2026.

Scope change

The bill's scope remains focused on Opioid Treatment Programs, but eligibility criteria for methadone administration have been expanded to include patients who are not enrolled at the specific OTP but can be verified as patients through other OTPs.

REQUIREMENT

Removed the requirement for observed urine drug testing, which may reduce patient privacy concerns and administrative burden.

Modified drug testing frequency requirements to align with federal regulations, potentially reducing the number of required tests.

ELIGIBILITY

Added provision allowing OTPs to administer methadone to patients not enrolled at their facility, provided the patient can be verified as enrolled at another OTP through contacting the home OTP, checking the central registry, or other Commission-established methods.

TIMELINE

Extended the deadline for the Commission to publish proposed amended rules from July 1, 2025 to January 1, 2026, giving regulators more time to develop and review rule changes.

Update Opioid Abatement Treatment Program Rules.

What changed between versions

How they voted

Actions timeline

Sponsors